Real World Data verify improved Treatment Results of Eltrombopag (Revolade (R)) from Novartis compared to other Second-line Therapies for Patients with Immune Thrombocytopenia (ITP)

首页> 外文期刊>Oncology research and treatment. >Real World Data verify improved Treatment Results of Eltrombopag (Revolade (R)) from Novartis compared to other Second-line Therapies for Patients with Immune Thrombocytopenia (ITP)

【24h】

Real World Data verify improved Treatment Results of Eltrombopag (Revolade (R)) from Novartis compared to other Second-line Therapies for Patients with Immune Thrombocytopenia (ITP)

机译：与免疫血小板减少症（ITP）患者的其他二线疗法相比，真实世界数据验证了从诺华的Eltrombopag（旋转（R））的治疗结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2019年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Real World Data verify improved Treatment Results of Eltrombopag (Revolade (R)) from Novartis compared to other Second-line Therapies for Patients with Immune Thrombocytopenia (ITP) [J] . Oncology research and treatment. . 2019,第1a2期

机译：与免疫血小板减少症（ITP）患者的其他二线疗法相比，真实世界数据验证了从诺华的Eltrombopag（旋转（R））的治疗结果
2. Real World Data show improved Treatment Results for Eltrombopag compared to other Second-line Therapies in ITP [J] . Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur? Transfusionsmedizin und Immunham?atologie . 2019,第1期

机译：与ITP中的其他二线疗法相比，现实世界数据显示改进的Eltompopag治疗结果
3. Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study [J] . Lucchini Elisa, Palandri Francesca, Volpetti Stefano, British Journal of Haematology . 2021,第2期

机译：Eltompagag二线治疗成年患者的原发性免疫血小板减少症试图达到持续缓解的脱离治疗：结果II期，多期，前瞻性研究
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. Brachytherapy Dosimetry: Working Towards Real-Time Treatment Verification in Modern HDR Brachytherapy [D] . Rokni, Michelle Beth. 2018

机译：近距离放射治疗剂量：在现代HDR近距离放射治疗中努力实现实时治疗核查
6. Use of Eltrombopag in Children With Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) [O] . Paola Giordano, Giuseppe Lassandro, Angelica Barone, 2020

机译：Eltrombopag在儿童慢性免疫性血小板减少症（ITP）中的使用：意大利儿科血液和肿瘤学协会（AIEOP）的真实生活回顾性多中心经验
7. PSY6 Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Where Surgery is Contraindicated in Colombia [O] . Vargas-Valencia J, Garcia Perlaza J 2015

机译：Romiplostim的PSY6成本-效果在难以接受其他治疗的成年脾脏切除患者中作为一线主要免疫血小板减少症（Itp）治疗和在哥伦比亚禁忌手术的成年非脾切除患者中作为二线Itp治疗

Real World Data verify improved Treatment Results of Eltrombopag (Revolade (R)) from Novartis compared to other Second-line Therapies for Patients with Immune Thrombocytopenia (ITP)

著录项

相似文献

相关主题

期刊订阅